Alamo Biologics
- Company typePrivate
- Founded1996
- HeadquartersSan Antonio, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Alamo Biologics firmographics
Firmographics- Name
- Alamo Biologics
- Legal name
- Alamo Biologics
- Website
- https://alamobiologics.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Alamo Biologics industry classification
Industry- Product category
- Allograft Tissue Banking
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Surgical Appliance and Supplies Manufacturing (339113), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Biologic API/Drug Substance Manufacturing Services (HLAAAKAA)
- akta.pro secondary industries
- Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF), Packaging, Labeling & Serialization for Biologics/ATMP (HLAGAGAJ)
Keywords
Where Alamo Biologics is headquartered
LocationHeadquarters
- HQ city
- San Antonio
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Alamo Biologics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Allograft Tissue Products: Alamo Biologics generates revenue through the sale of allograft tissue products including sports medicine grafts, specialty grafts, amnion/birth tissue, and general procedure tissues. Revenue is derived from product sales to healthcare providers including dental clinics, hospitals, surgical clinics, and other tissue banks. The company also offers contract manufacturing and custom product development services.
- Contract Manufacturing Services: The company provides turnkey solutions and custom designed products for customers requiring specific product specifications. This includes research and development, contract manufacturing, and storage facilities.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Alamo Biologics product offering
Product offeringCore offering
Alamo Biologics is a full-service tissue bank that recovers, processes, and distributes human allograft tissue products to healthcare providers. Its portfolio spans sports medicine grafts, specialty grafts (including PASCO2 DBM putty, Bio-Matrix+ products, cancellous bone void fillers, and pericardium), amniotic membrane patches (AmnioBioGraft/AmnioBioGraft+), and general procedure allografts for spinal, trauma, dental, and reconstructive surgery. The company also offers contract manufacturing, custom product development, and storage services to other tissue banks.
Product overview
Alamo Biologics is a full-service tissue bank offering a comprehensive portfolio of allograft tissue products and biologics. The company operates through two main divisions: its core tissue banking operations (Alamo Biologics) distributing Sports Medicine Grafts, Specialty Grafts (including PASCO2 DBM Putty, Bio-Matrix+, Bio-Matrix Fiber, Demineralized Cancellous products, and Pericardium), AmnioBioGraft and AmnioBioGraft+ (amniotic membrane products), and General Procedure Allografts; and its subsidiary Precision Allograft Solutions providing the proprietary PASCO2 supercritical CO2 technology platform for cleaning and sterilization of allograft tissues. The company distributes to dental clinics, hospitals, surgical clinics, and other tissue banks, offering research and development, contract manufacturing, and storage facilities. Services include custom product development for customers desiring bespoke solutions.
Differentiator
Problem solved
Functional benefit
Products and services
- Sports Medicine Grafts
Quantifiable outcome
- Allografts maintain biomechanical properties closer to natural tissues compared to gamma irradiation treatment
- +2 more outcomes
Companies that use Alamo Biologics
Customer profileSegments3 records
Ideal customer profiles3 records
Alamo Biologics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Alamo Biologics partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights5 records
Alamo Biologics competitors and assessment
Company assessmentEmerging players
- Organogenesis: Regenerative medicine company focused on advanced wound care and surgical biologics. Adjacent to Alamo's AmnioBioGraft wound-care line but with a more concentrated commercial focus on chronic wound applications.
Direct peers
- Xtant Medical: Regenerative medicine company focused on spine and orthopedic allografts, including demineralized bone matrices and sports medicine grafts. A direct competitor to Alamo in the orthopedic specialty graft segment.
- LifeNet Health: Non-profit allograft provider offering sports medicine grafts, demineralized bone matrices and amniotic membranes under the Allowash XG sterilization brand. Directly comparable to Alamo in sports medicine, specialty grafts and amnion tissue segments.
- MTF Biologics: The largest U.S. tissue bank, providing allografts for sports medicine, orthopedics, wound care and dental applications with a multi-state recovery network. Alamo Poached key talent from MTF (e.g., Jason Siegfried) and competes head-to-head in sports medicine grafts and DBM products.
- MiMedx Group: Specialty amniotic membrane and wound-care biologics company. Closely comparable to Alamo's AmnioBioGraft line for wound management, ocular and burn care applications.
- Vivex Biomedical: Specialty allograft and regenerative medicine company selling bone grafts, soft tissue grafts and amniotic products to orthopedic and wound-care markets. Overlaps with Alamo's sports medicine, specialty and amnion product lines.
- AlloSource: Non-profit tissue bank producing allografts for orthopedic, spine, sports medicine and burn/wound care. Competes with Alamo across sports medicine grafts, DBM putties and general procedure allografts distributed to hospitals and surgical centers.
- RTI Surgical: Developer of surgical implants including allograft-based spine, sports medicine and bone graft substitutes. Competes in Alamo's sports medicine, general procedure (spine/trauma) and DBM specialty graft categories.
Broad incumbents
- Integra LifeSciences: Large diversified medical device company with meaningful exposure to regenerative tissue technologies (e.g., DuraGen, amniotic membranes) and orthopedic specialty grafts. Broader portfolio and distribution scale than Alamo but overlaps in specialty tissue and wound-care channels.
- Stryker (Orthopedics): Global orthopedic medical device incumbent with sports medicine and biologics offerings that compete with Alamo's sports medicine grafts at the hospital/surgeon level. Wider portfolio and significantly greater commercial scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Alamo Biologics social profiles
Digital presenceAlamo Biologics compliance and trust
Trust signalCompliance4 records
Alamo Biologics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Alamo Biologics leadership team
Management profileNumber of profiles
Profiles8 records
Alamo Biologics subsidiaries and ownership
Company hierarchySubsidiaries1 record
Alamo Biologics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Alamo Biologics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Alamo Biologics
What does Alamo Biologics do?
Alamo Biologics is a full-service tissue bank that recovers, processes, and distributes human allograft tissue products to healthcare providers. Its portfolio spans sports medicine grafts, specialty grafts (including PASCO2 DBM putty, Bio-Matrix+ products, cancellous bone void fillers, and pericardium), amniotic membrane patches (AmnioBioGraft/AmnioBioGraft+), and general procedure allografts for spinal, trauma, dental, and reconstructive surgery. The company also offers contract manufacturing, custom product development, and storage services to other tissue banks.
Is Alamo Biologics a public or private company?
Alamo Biologics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Alamo Biologics founded?
Alamo Biologics was founded in 1996. It employs 51 to 100 people.
Where is Alamo Biologics based?
Alamo Biologics is headquartered in San Antonio, United States, in the North America region.
How does Alamo Biologics make money?
Two revenue lines are on record. Allograft Tissue Products are the primary driver. The others are contract Manufacturing Services.
Who are Alamo Biologics's main competitors?
Organogenesis is listed as an emerging player. Direct peers are Xtant Medical, LifeNet Health, MTF Biologics, MiMedx Group, Vivex Biomedical, AlloSource and RTI Surgical. Broad incumbents are Integra LifeSciences and Stryker (Orthopedics).
Does Alamo Biologics have an API?
No public API is recorded for Alamo Biologics.
What industry is Alamo Biologics in?
Alamo Biologics's product category is Allograft Tissue Banking. Its primary akta.pro industry code is HLAAAKAA, Biologic API/Drug Substance Manufacturing Services, with a secondary code of HLAAAKAF, Process Development & Tech Transfer Services (upstream/downstream). Its NAICS code is 325414 and its SIC code is 2836.